News - Zetia, Research

Filter

Current filters:

ZetiaResearch

Popular Filters

Amgen’s evolocumab beats Zetia in Ph III GAUSS-2 trial for cholesterol reduction

Amgen’s evolocumab beats Zetia in Ph III GAUSS-2 trial for cholesterol reduction

24-01-2014

USA-based Amgen yesterday revealed positive results from the Phase III GAUSS-2 (Goal Achievement After…

AmgenBiotechnologyCardio-vascularevolocumabResearchZetia

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top